PATENT CLAIM ANALYSIS

Application Number: 15751802
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure generally relates to methods for treating, preventing, inhibiting the progression of or reducing the likelihood of occurrence of a myocardial infarction-related complication, a cardiac disorder characterised by abnormal conduction and other cardiac conditions. The present disclosure also generally relates to one or more inhibitors of Connexin 45.

Claim (Index 36):
A cell comprising the nucleic acid of  claim 28 .

Metadata:
- Claim Count in Document: 54.0
- Percentile: 88.0
- Lexical Diversity: 1.41026
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14357195', '15813469', '12811306', '12960313', '09376317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589186656357791
- 35 USC 102 Novelty (BERT): 0.5078358335685649
- Combined Prediction Score: 0.7338103824290577
- Mean Citation Score: 238.179764
- Max Citation Score: 248.25278
- Similarity Product: 157.16227328594684

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test